Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study aims to investigate the benefits of methimazole treatment in patients with hyperthyroidism, associated with supplementation of L-carnitine and Selenium.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| methimazole (control) | No Intervention | Patients with hyperthyroidism under methimazole treatment | |
| methimazole+L-carnitine+selenium (intervention) | Experimental | Patients with hyperthyroidism under methimazole treatment + supplementation with L-carnitine and Selenium |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| L-carnitine+Selenium | Dietary Supplement | Supplementation with L-carnitine and Selenium |
|
| Measure | Description | Time Frame |
|---|---|---|
| Hyperthyroidism symptoms | Improvement of the patients' quality of life through questionnaire | Change from baseline QoL at 6 months of supplementation |
| Hyperthyroidism symptoms | Improvement of the patients' quality of life through questionnaire | Change from 6-months supplementation QoL at 12 months of intervention (end of study) |
| Measure | Description | Time Frame |
|---|---|---|
| TRAb | Change in serum TRAb (TSH receptor antibodies) | Four time points: baseline; after 3 months of supplementation; after 6 months of supplementation; end of the study (12 months) |
| TSH | Change in serum TSH (Thyroid stimulating hormone) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Azienda Ospedaliero-Universitaria Città della scienza e degli studi di Torino | Torino | 10126 | Italy |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006980 | Hyperthyroidism |
| ID | Term |
|---|---|
| D013959 | Thyroid Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Four time points: baseline; after 3 months of supplementation; after 6 months of supplementation; end of the study (12 months) |